Back to search

National and Kapodistrian University of Athens

Γενετικοί πολυμορφισμοί του άξονα ρενίνης - αγγειοτασίνης - αλδοστερόνης σε σχέση με την ανταπόκριση της αρτηριακής πίεσης στην αναστολή του μετατρεπτικού ενζύμου της αγγειοτασίνης ή τον αποκλεισμό των τύπου 1 υποδοχέων της αγγειοτασίνης

Abstract

dc:description

This study aimed to investigate the association between ι) polymorphisms of the angiotensin converting enzyme (ACE)angiotensinogen (AGT) angiotensin type-1 receptor (ATiR) and adducin (ADC) genes and ιι) the antihypertensive responseto ACE inhibition and ATiR blockade Thirty two untreated hypertensives were randomized to receive for 5 weeks the ATiRblocker telmisartan (80 mg) or the ACE inhibitor lisinopnl (20 mg) Patients were then crossed-over to the alternativetreatment for a second 5 week penod Twenty four hour ambulatory blood pressure (ABP) was measured beforerandomizatjon and on the final day of each treatment penod (study 1) The same cross-over design was used in a study on27 untreated hypertensives randomized to the ATiR blocker losartan (50 mg) or lisinopnl (20 mg) (study 2) Polymerasechain reaction was used for the asserire·1* ο* the fc' owing gene polymorhisms ACE insertion/deletion AGT MT235 ATiRA1166C and ADC Gly460Trp Subjects were classified as responders and nonresponders using as a threshold an arbitrarylevel of response (diastolic ABP fall >10 mm Hg) or the median ABP response achieved by each of the drugs Theassociation between polymorphisms and BP response was examined by one-way analysis of variance and multiplecontingency table analysis No difference was detected between lisinopnl and telmisartan in their effect on ABP in study 1(mean difference 1 2±7 1 95% CI 14 38 mmHg [systolic]/0 7±5 1 95% CI 12 2 5 mmHg [diastolic]) whereas lisinopnlwas more effective than losartan in reducing ABP in study 2 (mean difference 5 1±8 5 95% CI 1 7 8 5 mmHg p<0 01[systolic]/3 5±6 1 95% CM 1 5 9 mmHg p<0 01 [diastolic]) Differences in average ABP decline between polymorphism subgroups were non significant for all 4 genes studied for both systolic and diastolic BP in both studies No specific patternof genotyping was detected for responders and non responders to each drug whereas no association was found in thegenotyping pattern of responders to lisinopnl between the two studies There seems to be no significant association betweenthe investigated genotypes and the ABP response to ACE inhibition or ATiR blockade Moreover no specific genotypingprofile appears to charactenze responders and non responders to these two drug classesnapoc>-

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2006

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Eustathiou, Stamatios
  • Ευσταθίου, Σταμάτιος

Subjects

dc:subject × 18

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/24928

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Eustathiou, Stamatios; Ευσταθίου, Σταμάτιος. Γενετικοί πολυμορφισμοί του άξονα ρενίνης - αγγειοτασίνης - αλδοστερόνης σε σχέση με την ανταπόκριση της αρτηριακής πίεσης στην αναστολή του μετατρεπτικού ενζύμου της αγγειοτασίνης ή τον αποκλεισμό των τύπου 1 υποδοχέων της αγγειοτασίνης. National and Kapodistrian University of Athens, 2006. http://hdl.handle.net/10442/hedi/24928